News from NYU Langone Health
A heart-stopping series: How to stay healthy while watching the Knicks
Spectrum News NY1
Gregory Katz, MD, a cardiologist and site director of Inpatient Unit at Tisch Hospital, as well as associate program director in the Internal Medicine Residency Program at NYU Grossman School of Medicine, shared health tips on NY1 News All Day for fans watching the New York Knicks during the playoffs. He noted that intense sporting events can cause adrenaline levels and blood pressure to rise, creating stress on the body. Dr. Katz recommended that fans take short mental breaks and step away from the game momentarily to help regulate their heart rate.
On ABC7 Eyewitness News, Shaline Rao, MD, director of heart failure services, chief of Cardiology, chief and vice chair of Operations of Medicine at NYU Langone Hospital - Long Island, said fans with underlying conditions like hypertension or stents, should take deep breaths and incorporate dynamic movement—such as walking around—to improve blood flow during the game. Dr. Rao also emphasized the importance of staying hydrated and limiting alcohol consumption to manage cardiovascular stress.
6/10/2026
W. R. Berkley Corp. founder William Berkley dies at 80
Westchester County Business Journal
William R. Berkley, founder of W. R. Berkley Corp. and chairman emeritus of New York University’s Board of Trustees, has died at age 80. He served as a member of the Board of Trustees of NYU Langone Health and was named an honorary alumnus of the NYU Grossman School of Medicine. Berkley also received the Valentine Mott Award from NYU Langone Health for his exceptional support and leadership. He is survived by family including his son-in-law, John Saunders, MD, clinical associate professor in NYU Langone's Department of Surgery.
6/10/2026
Tiny walking changes could slow knee arthritis down
HuffPost UK
Research published in The Lancet Rheumatology indicates that minor adjustments to a person's foot position while walking can slow the progression of knee arthritis. The study found that participants trained to walk with an optimized foot angle experienced slower knee cartilage degeneration and a significant reduction in pain. According to study co-author Valentina Mazzoli, PhD, assistant professor in the Department of Radiology at NYU Grossman School of Medicine, these findings suggest a personalized, noninvasive treatment could help delay the need for surgery. The intervention could offer an inexpensive way to address early-stage osteoarthritis.
6/10/2026
Could drinking one glass of this a day help your depression?
Women's Health
A new study suggests that consuming one portion of daily recommended fruits and vegetables as juice or a smoothie could help protect against depression. Commenting on the findings, Thea Gallagher, PsyD, director of Wellness Programs at NYU Langone Health and clinical associate professor of psychiatry at NYU Grossman School of Medicine, advises caution. She suggests that the benefit may come from an overall healthy diet, which is already linked to a lower risk of depression, rather than from drinking fruit juice alone. Gallagher adds that juice or smoothies can be a practical tool to help some people meet their daily fruit and vegetable intake, which may support mental wellbeing.
Also reporting was: Aol, Yahoo Health
6/10/2026
Optimizing perioperative therapy in triple-negative breast cancer
MedPage Today
The treatment landscape for early-stage triple-negative breast cancer is evolving following the KEYNOTE-522 trial, which established a new standard of care. According to Iris Zhi, MD, PhD, interim chief of Division of Hematology and Oncology and medical director of Clinical Operations, Medical Oncology, Perlmutter Cancer Center - Long Island, the trial was pivotal but left questions unanswered, particularly for patients ineligible for certain chemotherapies. To address this, NYU Langone is planning the investigator-initiated NeoCARD clinical trial. The trial will evaluate an alternative chemotherapy backbone for anthracycline-ineligible patients. Dr. Zhi also commented on the ongoing research into better treatments for patients with residual disease after initial therapy.
Also reporting was: MedPage Today, News Health, News Health, MSN
6/10/2026
Ozempic may be a secret weapon against ADHD: ‘I have literally never felt so relaxed in my life’
New York Post
Anecdotal reports suggest GLP-1 drugs like Ozempic may ease ADHD symptoms, a phenomenon observed in clinical practice by Lenard Adler, MD, director of the Adult ADHD Program at NYU Langone Health, vice chair for education, and the Carter A. Pottash Professor of Psychiatry, Department of Psychiatry at NYU Grossman School of Medicine. Adler notes that while data is limited, a notable number of his patients on these medications have reported improvements. He explains the drugs may affect the brain's reward centers, potentially influencing impulse control and motivation. Adler also suggests that benefits could be linked to weight loss and lifestyle changes, and he stresses the need for further research into the potential effects and side effects.
Also reporting was: Aol
6/10/2026
Holy Cross community rallies to help beloved teacher find liver donor
The Tablet (Brooklyn, NY)
Blaine Palmer, a teacher at Holy Cross High School, is searching for a living liver donor after a diagnosis of colon cancer that spread to his liver. The screening process for potential donors is being conducted through NYU Langone Health’s Living Donor Liver Transplant Program. Palmer has also been receiving ongoing care from his medical team at NYU Langone Health. The school community has launched an outreach campaign to help him find a medically compatible donor, with the hope of finding one by August.
6/10/2026
Vaccine cuts melanoma recurrence nearly in half
Newsmax
A personalized mRNA cancer vaccine from Moderna and Merck, combined with the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence by 49% in high-risk patients. The findings were presented at the 2026 American Society of Clinical Oncology annual meeting. According to senior investigator Janice Mehnert, MD, a professor at NYU Grossman School of Medicine, director of the Melanoma Medical Oncology Program, and associate director of Clinical Research at Perlmutter Cancer Center, the study offers strong evidence that the combination therapy can demonstrably reduce cancer's return and improve clinical outcomes for melanoma patients.
Also reporting was: Yahoo
6/10/2026
FDA approves first new sunscreen ingredient in over 20 years — here’s what it means for older adults
AARP
The FDA has approved bemotrizinol, the first new active sunscreen ingredient in over two decades, which protects against both UVA and UVB rays. Dermatologists anticipate this will lead to sunscreens with a more lightweight and pleasant texture, encouraging daily use. According to Jennifer Stein, MD, PhD, dermatologist at NYU Langone Health, associate vice chair of Faculty Group Practice, and the Stewart J. Rahr Professor of Dermatology, Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine, the new ingredient offers another safe, effective, and cosmetically elegant option for consumers. Experts from Mount Sinai and Memorial Sloan Kettering also commented on the ingredient's benefits.
Also reporting was: TODAY, Honolulu Star-Advertiser
6/10/2026
Difficulty conceiving tied to small neurodevelopmental differences in children
Medical Xpress
A new study in JAMA Network Open suggests that parental fertility challenges, rather than fertility treatments themselves, may be linked to small neurodevelopmental differences in children. The research, which analyzed over 15,000 mother-child pairs, found that children of parents with fertility issues had slightly higher behavior-problem scores and odds of an autism diagnosis, even if conceived naturally. According to study researcher Linda Kahn, PhD, MPH, assistant professor of pediatrics and population health at NYU Grossman School of Medicine, the findings indicate that parents' underlying fertility problems are likely driving these associations, not the treatments.
6/10/2026
NeurologyLive
Following NYU Langone's Brain Health Media Roundtable, Jinsy Andrews, MD, a neurologist, director of NYU Langone's ALS Center, and medical director of Clinical Trials, discussed the state of amyotrophic lateral sclerosis (ALS) drug development. She highlighted the conditional approval of tofersen for SOD1-ALS as a game-changer, opening the door for antisense oligonucleotide technology. Looking ahead, Andrews noted the pipeline for 2026 includes a FUS gene-targeted ASO and the ATLAS study for presymptomatic individuals. She also emphasized the evolving focus on prodromal ALS and the need for new biomarkers beyond neurofilament light chain.
6/10/2026
Why dietitians say most people ignore this longevity food
Yahoo Health
Researchers have identified beans as a key food for longevity, with studies linking their consumption to a lower risk of death. According to Samantha Heller, MS, RDN, CDN, senior clinical nutritionist at NYU Langone Health, one cup of legumes provides five to ten grams of protein, four to fourteen grams of fiber, and essential minerals like potassium, calcium, and iron. Heller also notes that beans contain powerful antioxidant compounds that fight inflammation at the cellular level. Longevity researcher Dan Buettner has called beans the cornerstone of every longevity diet in the world.
6/10/2026
4 lifestyle changes that lower bad cholesterol better than statins
Mercola.com
Adriana Quinones-Camacho, MD, a cardiologist at NYU Langone Health and chief of medicine at Tisch Hospital, advises that four lifestyle changes can help manage cholesterol levels better than statins. She recommends being physically active, losing excess weight, consuming healthy fats, and eating more fiber while reducing processed sugar. Quinones-Camacho suggests physicians should recommend these strategies to patients before prescribing statins. The article also discusses the author's perspective on saturated fats and omega-3s, as well as the potential side effects of statin medications.
6/11/2026
WDJT-TV (Milwaukee, WI)
More women are alleging that former Wisconsin OB-GYN Frederick G. Dettmann artificially inseminated them with his own sperm without their consent in the 1980s. In response to the allegations, Arthur Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics and founding head of the Division of Medical Ethics at NYU Grossman School of Medicine’s Department of Population Health, commented on the prevalence of fertility fraud. He noted that such cases are often discovered through genetic testing and described fertility clinics of that era as the 'wild west' due to a lack of regulation, calling the alleged actions 'absolute medical malpractice.' An attorney for the victims plans to file a civil case.
6/10/2026
